In
an effort to improve on the efficiency of running endocrine
function, hormones, toxicology, abused drugs, and immunosuppressants
tests, Abbott introduced the TDxFLx in 1991 which
incorporates random access capabilities. Although the
therapeutic drug monitoring market has undergone several
important changes in the past 20 years, Abbott continues
to lead the way.
TDxFLx
Test Listing
|
